Adenosine receptor targeting in health and disease

Expert Opin Investig Drugs. 2011 Dec;20(12):1591-609. doi: 10.1517/13543784.2011.627853. Epub 2011 Oct 22.

Abstract

Introduction: The adenosine receptors A(1), A(2A), A(2B) and A(3) are important and ubiquitous mediators of cellular signaling that play vital roles in protecting tissues and organs from damage. In particular, adenosine triggers tissue protection and repair by different receptor-mediated mechanisms, including increasing the oxygen supply:demand ratio, pre-conditioning, anti-inflammatory effects and the stimulation of angiogenesis.

Areas covered: The state of the art of the role of adenosine receptors which have been proposed as targets for drug design and discovery, in health and disease, and an overview of the ligands for these receptors in clinical development.

Expert opinion: Selective ligands of A(1), A(2A), A(2B) and A(3) adenosine receptors are likely to find applications in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature. The aim of this review is to provide an overview of the present knowledge regarding the role of these adenosine receptors in health and disease.

Publication types

  • Review

MeSH terms

  • Adenosine / metabolism
  • Disease*
  • Drug Discovery
  • Health*
  • Humans
  • Molecular Targeted Therapy*
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / physiology*
  • Signal Transduction / physiology

Substances

  • Receptors, Purinergic P1
  • Adenosine